Prognosis prediction and comparison between pancreatic signet ring cell carcinoma and pancreatic duct adenocarcinoma: a retrospective observational study
H Zhou, X Li, Y Huang, Y Wang, H Zou… - Frontiers in …, 2023 - frontiersin.org
Background Pancreatic signet ring cell carcinoma (PSRCC) is a rare and aggressive cancer
that has been reported primarily as case reports. Due to limited large-scale epidemiological …
that has been reported primarily as case reports. Due to limited large-scale epidemiological …
Effects of TP regimen combined with intraperitoneal hyperthermic perfusion chemotherapy on immune function, quality of life and prognosis of patients with advanced …
Q Shu, J Zheng, X Luo, K Wang - American Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: To evaluate the effect of paclitaxel and cisplatin (TP regimen) combined with
intraperitoneal hyperthermic perfusion chemotherapy on immune function and quality of life …
intraperitoneal hyperthermic perfusion chemotherapy on immune function and quality of life …
[HTML][HTML] Benchmarking of Approaches for Gene Copy-Number Variation Analysis and Its Utility for Genetic Aberration Detection in High-Grade Serous Ovarian …
PA Grebnev, IO Meshkov, PV Ershov, AV Makhotenko… - Cancers, 2024 - mdpi.com
Simple Summary Our research integrates two key areas of focus. We first focus on a
comparative biostatistical analysis of the agreement between three laboratory methods for …
comparative biostatistical analysis of the agreement between three laboratory methods for …
Pancreatic mucinous adenocarcinoma has different clinical characteristics and better prognosis compared to non-specific PDAC: A retrospective observational study
J Liu, Y Zhang, J Zhou, Z Zhang, Y Wen - Heliyon, 2024 - cell.com
Background Pancreatic mucinous adenocarcinoma (PMAC) is a rare malignant tumour, and
there is limited understanding of its epidemiology and prognosis. Initially, PMAC was …
there is limited understanding of its epidemiology and prognosis. Initially, PMAC was …